Global Med Technologies, Inc. (OTC BB: GLOB), an international medical software company, is focused on developing regulated and non-regulated software products and services for application in the medical field. The company’s products are currently deployed in 20 countries and serve more than 1,600 transfusion centers, blood banks and laboratories. Global Med’s U.S. division provides Vein-to- Vein® tracking through its Donor Doc(TM), SafeTrace®, SafeTrace Tx® and ElDorado Donor(TM) software products. For further information, visit the Company’s web site at www.wyndgate.com.
- 18 years ago
QualityStocks
Global Med Technologies, Inc. (OTC BB: GLOB)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…